AGP Executive Report
Last update: 6 hours agoNHS & Weight-Loss Jabs: Scotland’s medicines watchdog has accepted semaglutide (Wegovy) on the NHS to cut cardiovascular risk in adults with established heart disease who are overweight or obese, adding a new prevention option beyond weight management. Diabetes/Obesity Supply Limits: NHS England says tirzepatide rollout can’t speed up in primary care because of the scale of prescribing support needed. NHS Data & Cybersecurity: A review of the Synnovis ransomware breach reports stolen patient records resurfacing online, with at least one trust saying thousands of files were taken and patients were notified. AI in the NHS: Britain is reviewing its £330m Palantir NHS contract amid political pressure over confidentiality and reliance on a US supplier, with a break clause decision looming in early 2027. Patient Safety Scandal: Wales’ Royal Gwent Hospital sterilisation unit is under fresh scrutiny after whistleblowers claim concerns were raised years before a major blunder. Public Health & Lifestyle: A UK Biobank study links small daily improvements in sleep, activity and diet to extra years of healthy life. Mental Health & Youth: Campaigners warn smartphone and social media use is driving a public health emergency for young people, as calls grow for stronger protections. Community Health: A Welsh football fan has died after a battle with an aggressive brain tumour, highlighting gaps in access to treatments beyond the NHS.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.